Methylprednisolone

This page shows anti-doping rule violation data we have registered for Methylprednisolone.

Number of cases in Methylprednisolone Last 10 Years

Methylprednisolone

Methylprednisolone ranks #88 globally among prohibited substances, with 26 registered cases (0.2% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,828 verified cases. Kenya leads with 6 cases, while Track and field is the most affected sport (12 cases).

Cases of Methylprednisolone by Sport
Track and field
12
Cycling
4
Soccer
2
Equestrian
2
Fencing
1
Top Sport: Track and field

12

Track and field cases

0%

Of all violations

26

Total Methylprednisolone cases
Track and field's share of Methylprednisolone violations 0%
12 of 26

Track and field has the most recorded cases of Methylprednisolone violations globally, with 12 registered cases — 0% of all 26 verified cases.

Cases of Methylprednisolone by Country
Kenya
6
USA
2
Italy
2
Portugal
2
Brazil
2
Top Country: Kenya

6

Kenya cases

23.1%

Of all violations

26

Total Methylprednisolone cases
Kenya's share of Methylprednisolone violations 23.1%
6 of 26

Kenya leads significantly in Methylprednisolone violations globally, with 6 registered cases — 23.1% of all 26 verified cases.

Global Substance Ranking

Methylprednisolone ranks #88 of 360 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,379
#2 Methandienone
843
#3 Norandrosterone
787
#4 Testosterone
772
···
#88 Methylprednisolone
26
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 76.9%
20 cases
Female 23.1%
6 cases
Analysis: 's gender distribution (76.9% male, 23.1% female) aligns closely with the global average. Global average: 80.1% male, 19.9% female
Average Suspension Length
12.9
months
Methylprednisolone
30.2
months
Global average

The average suspension for Methylprednisolone violations is 12.9 months, shorter than the global average of 30.2 months.

Methylprednisolone, a corticosteroid, is similar to a natural hormone produced by your adrenal glands. It is often used to replace this chemical when your body does not make enough of it. It relieves inflammation (swelling, heat, redness, and pain) and is used to treat certain forms of arthritis; skin, blood, kidney, eye, thyroid, and intestinal disorders (e.g., colitis); severe allergies; and asthma. Methylprednisolone is also used to treat certain types of cancer. (Source: MedlinePlus - http://www.nlm.nih.gov/) This systemic glucocorticosteroid was first listed in the IOC doping list in 1995. Prohibited by certain routes such as oral, intravenous and intramuscular.

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,828 verified anti-doping rule violations across all sports and all countries, and is updated regularly.